ExodusPoint Capital Management, LP - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 67 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$120,000
+93.5%
14,548
+31.7%
0.00%
+100.0%
Q1 2022$62,000
+17.0%
11,044
-2.0%
0.00%0.0%
Q4 2021$53,000
-89.3%
11,264
-85.0%
0.00%
-80.0%
Q2 2021$494,000
+236.1%
75,015
+273.7%
0.01%
+150.0%
Q1 2021$147,000
-24.6%
20,072
-47.1%
0.00%
-60.0%
Q2 2020$195,00037,9240.01%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,739,255$22,544,0007.01%
Worth Venture Partners, LLC 685,026$5,638,0003.45%
NEA Management Company, LLC 3,952,957$32,533,0001.62%
Birchview Capital, LP 140,000$1,152,0000.81%
Rubric Capital Management LP 1,664,667$13,700,0000.69%
EAM Investors, LLC 380,691$3,133,0000.68%
GLOBEFLEX CAPITAL L P 368,520$3,033,0000.52%
X-Square Capital, LLC 92,283$759,0000.48%
EAM Global Investors LLC 211,759$1,743,0000.46%
J. Goldman & Co LP 656,161$5,400,0000.26%
View complete list of AVEO PHARMACEUTICALS INC shareholders